Michael T. Kidd
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas System (2026)
Research Areas
Biography and Research Information
OverviewAI-generated summary
Michael T. Kidd's research focuses on animal science, specifically investigating methods to improve broiler chicken health and productivity. His recent publications explore the impact of dietary supplementation, such as Arthrospira (Spirulina) platensis, on breast yield in heat-stressed broilers by modulating the proteostasis network. Kidd has also examined the timing of 1,25(OH)2D3-glycoside inclusion to mitigate lameness caused by bacterial chondronecrosis with osteomyelitis in broilers. Additionally, his work includes developing technological solutions, such as the VentVision system, which utilizes multimodal vision for automated vent-based chick sexing. These studies contribute to understanding and enhancing animal welfare and production efficiency within the poultry industry.
Metrics
- Publications: 3
Selected Publications
-
Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers (2026)
Collaboration Network
Top Collaborators
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
Similar Researchers
Based on overlapping research topics